Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive Impairment Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antiepileptic Drugs Cognitive Impairment Disorders Treatment
1.2.3 Antipsychotics Drugs Cognitive Impairment Disorders Treatment
1.3 Market by Application
1.3.1 Global Cognitive Impairment Disorders Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Specialty Clinics
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cognitive Impairment Disorders Treatment Market Perspective (2018-2033)
2.2 Cognitive Impairment Disorders Treatment Growth Trends by Region
2.2.1 Global Cognitive Impairment Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cognitive Impairment Disorders Treatment Historic Market Size by Region (2018-2023)
2.2.3 Cognitive Impairment Disorders Treatment Forecasted Market Size by Region (2024-2033)
2.3 Cognitive Impairment Disorders Treatment Market Dynamics
2.3.1 Cognitive Impairment Disorders Treatment Industry Trends
2.3.2 Cognitive Impairment Disorders Treatment Market Drivers
2.3.3 Cognitive Impairment Disorders Treatment Market Challenges
2.3.4 Cognitive Impairment Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive Impairment Disorders Treatment Players by Revenue
3.1.1 Global Top Cognitive Impairment Disorders Treatment Players by Revenue (2018-2023)
3.1.2 Global Cognitive Impairment Disorders Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Cognitive Impairment Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cognitive Impairment Disorders Treatment Revenue
3.4 Global Cognitive Impairment Disorders Treatment Market Concentration Ratio
3.4.1 Global Cognitive Impairment Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive Impairment Disorders Treatment Revenue in 2022
3.5 Cognitive Impairment Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Cognitive Impairment Disorders Treatment Product Solution and Service
3.7 Date of Enter into Cognitive Impairment Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive Impairment Disorders Treatment Breakdown Data by Type
4.1 Global Cognitive Impairment Disorders Treatment Historic Market Size by Type (2018-2023)
4.2 Global Cognitive Impairment Disorders Treatment Forecasted Market Size by Type (2024-2033)
5 Cognitive Impairment Disorders Treatment Breakdown Data by Application
5.1 Global Cognitive Impairment Disorders Treatment Historic Market Size by Application (2018-2023)
5.2 Global Cognitive Impairment Disorders Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cognitive Impairment Disorders Treatment Market Size (2018-2033)
6.2 North America Cognitive Impairment Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023)
6.4 North America Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cognitive Impairment Disorders Treatment Market Size (2018-2033)
7.2 Europe Cognitive Impairment Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023)
7.4 Europe Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cognitive Impairment Disorders Treatment Market Size (2018-2033)
8.2 Asia-Pacific Cognitive Impairment Disorders Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cognitive Impairment Disorders Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Cognitive Impairment Disorders Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cognitive Impairment Disorders Treatment Market Size (2018-2033)
9.2 Latin America Cognitive Impairment Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023)
9.4 Latin America Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive Impairment Disorders Treatment Market Size (2018-2033)
10.2 Middle East & Africa Cognitive Impairment Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Cognitive Impairment Disorders Treatment Introduction
11.1.4 Eli Lilly and Company Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.1.5 Eli Lilly and Company Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cognitive Impairment Disorders Treatment Introduction
11.2.4 AstraZeneca Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Cognitive Impairment Disorders Treatment Introduction
11.4.4 Pfizer Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Minerva Neurosciences
11.5.1 Minerva Neurosciences Company Detail
11.5.2 Minerva Neurosciences Business Overview
11.5.3 Minerva Neurosciences Cognitive Impairment Disorders Treatment Introduction
11.5.4 Minerva Neurosciences Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.5.5 Minerva Neurosciences Recent Development
11.6 Intra-Cellular Therapies
11.6.1 Intra-Cellular Therapies Company Detail
11.6.2 Intra-Cellular Therapies Business Overview
11.6.3 Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Introduction
11.6.4 Intra-Cellular Therapies Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.6.5 Intra-Cellular Therapies Recent Development
11.7 Avineuro Pharmaceuticals
11.7.1 Avineuro Pharmaceuticals Company Detail
11.7.2 Avineuro Pharmaceuticals Business Overview
11.7.3 Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Introduction
11.7.4 Avineuro Pharmaceuticals Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.7.5 Avineuro Pharmaceuticals Recent Development
11.8 SyneuRx
11.8.1 SyneuRx Company Detail
11.8.2 SyneuRx Business Overview
11.8.3 SyneuRx Cognitive Impairment Disorders Treatment Introduction
11.8.4 SyneuRx Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.8.5 SyneuRx Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Detail
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Cognitive Impairment Disorders Treatment Introduction
11.9.4 Lundbeck Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.9.5 Lundbeck Recent Development
11.10 AB Science SA
11.10.1 AB Science SA Company Detail
11.10.2 AB Science SA Business Overview
11.10.3 AB Science SA Cognitive Impairment Disorders Treatment Introduction
11.10.4 AB Science SA Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.10.5 AB Science SA Recent Development
11.11 AbbVie Inc
11.11.1 AbbVie Inc Company Detail
11.11.2 AbbVie Inc Business Overview
11.11.3 AbbVie Inc Cognitive Impairment Disorders Treatment Introduction
11.11.4 AbbVie Inc Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.11.5 AbbVie Inc Recent Development
11.12 CHA Bio & Diostech Co Ltd
11.12.1 CHA Bio & Diostech Co Ltd Company Detail
11.12.2 CHA Bio & Diostech Co Ltd Business Overview
11.12.3 CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Introduction
11.12.4 CHA Bio & Diostech Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.12.5 CHA Bio & Diostech Co Ltd Recent Development
11.13 Echo Pharmaceuticals BV
11.13.1 Echo Pharmaceuticals BV Company Detail
11.13.2 Echo Pharmaceuticals BV Business Overview
11.13.3 Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Introduction
11.13.4 Echo Pharmaceuticals BV Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.13.5 Echo Pharmaceuticals BV Recent Development
11.14 Eisai Co Ltd
11.14.1 Eisai Co Ltd Company Detail
11.14.2 Eisai Co Ltd Business Overview
11.14.3 Eisai Co Ltd Cognitive Impairment Disorders Treatment Introduction
11.14.4 Eisai Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.14.5 Eisai Co Ltd Recent Development
11.15 GlaxoSmithKline Plc
11.15.1 GlaxoSmithKline Plc Company Detail
11.15.2 GlaxoSmithKline Plc Business Overview
11.15.3 GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Introduction
11.15.4 GlaxoSmithKline Plc Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.15.5 GlaxoSmithKline Plc Recent Development
11.16 Grifols SA
11.16.1 Grifols SA Company Detail
11.16.2 Grifols SA Business Overview
11.16.3 Grifols SA Cognitive Impairment Disorders Treatment Introduction
11.16.4 Grifols SA Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.16.5 Grifols SA Recent Development
11.17 Immungenetics AG
11.17.1 Immungenetics AG Company Detail
11.17.2 Immungenetics AG Business Overview
11.17.3 Immungenetics AG Cognitive Impairment Disorders Treatment Introduction
11.17.4 Immungenetics AG Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.17.5 Immungenetics AG Recent Development
11.18 Otsuka Holdings Co Ltd
11.18.1 Otsuka Holdings Co Ltd Company Detail
11.18.2 Otsuka Holdings Co Ltd Business Overview
11.18.3 Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Introduction
11.18.4 Otsuka Holdings Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.18.5 Otsuka Holdings Co Ltd Recent Development
11.19 Merck & Co Inc
11.19.1 Merck & Co Inc Company Detail
11.19.2 Merck & Co Inc Business Overview
11.19.3 Merck & Co Inc Cognitive Impairment Disorders Treatment Introduction
11.19.4 Merck & Co Inc Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.19.5 Merck & Co Inc Recent Development
11.20 Kyowa Hakko Kirin Co Ltd
11.20.1 Kyowa Hakko Kirin Co Ltd Company Detail
11.20.2 Kyowa Hakko Kirin Co Ltd Business Overview
11.20.3 Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Introduction
11.20.4 Kyowa Hakko Kirin Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023)
11.20.5 Kyowa Hakko Kirin Co Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cognitive Impairment Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antiepileptic Drugs Cognitive Impairment Disorders Treatment
Table 3. Key Players of Antipsychotics Drugs Cognitive Impairment Disorders Treatment
Table 4. Global Cognitive Impairment Disorders Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Cognitive Impairment Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cognitive Impairment Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cognitive Impairment Disorders Treatment Market Share by Region (2018-2023)
Table 8. Global Cognitive Impairment Disorders Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cognitive Impairment Disorders Treatment Market Share by Region (2024-2033)
Table 10. Cognitive Impairment Disorders Treatment Market Trends
Table 11. Cognitive Impairment Disorders Treatment Market Drivers
Table 12. Cognitive Impairment Disorders Treatment Market Challenges
Table 13. Cognitive Impairment Disorders Treatment Market Restraints
Table 14. Global Cognitive Impairment Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cognitive Impairment Disorders Treatment Market Share by Players (2018-2023)
Table 16. Global Top Cognitive Impairment Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognitive Impairment Disorders Treatment as of 2022)
Table 17. Ranking of Global Top Cognitive Impairment Disorders Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cognitive Impairment Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cognitive Impairment Disorders Treatment Product Solution and Service
Table 21. Date of Enter into Cognitive Impairment Disorders Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cognitive Impairment Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cognitive Impairment Disorders Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Cognitive Impairment Disorders Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cognitive Impairment Disorders Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Cognitive Impairment Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cognitive Impairment Disorders Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Cognitive Impairment Disorders Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cognitive Impairment Disorders Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Cognitive Impairment Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Cognitive Impairment Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Cognitive Impairment Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Cognitive Impairment Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cognitive Impairment Disorders Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Cognitive Impairment Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Cognitive Impairment Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Cognitive Impairment Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cognitive Impairment Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Eli Lilly and Company Company Detail
Table 47. Eli Lilly and Company Business Overview
Table 48. Eli Lilly and Company Cognitive Impairment Disorders Treatment Product
Table 49. Eli Lilly and Company Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 50. Eli Lilly and Company Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Cognitive Impairment Disorders Treatment Product
Table 54. AstraZeneca Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Product
Table 59. Bristol-Myers Squibb Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Cognitive Impairment Disorders Treatment Product
Table 64. Pfizer Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Minerva Neurosciences Company Detail
Table 67. Minerva Neurosciences Business Overview
Table 68. Minerva Neurosciences Cognitive Impairment Disorders Treatment Product
Table 69. Minerva Neurosciences Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 70. Minerva Neurosciences Recent Development
Table 71. Intra-Cellular Therapies Company Detail
Table 72. Intra-Cellular Therapies Business Overview
Table 73. Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Product
Table 74. Intra-Cellular Therapies Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 75. Intra-Cellular Therapies Recent Development
Table 76. Avineuro Pharmaceuticals Company Detail
Table 77. Avineuro Pharmaceuticals Business Overview
Table 78. Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Product
Table 79. Avineuro Pharmaceuticals Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 80. Avineuro Pharmaceuticals Recent Development
Table 81. SyneuRx Company Detail
Table 82. SyneuRx Business Overview
Table 83. SyneuRx Cognitive Impairment Disorders Treatment Product
Table 84. SyneuRx Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 85. SyneuRx Recent Development
Table 86. Lundbeck Company Detail
Table 87. Lundbeck Business Overview
Table 88. Lundbeck Cognitive Impairment Disorders Treatment Product
Table 89. Lundbeck Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 90. Lundbeck Recent Development
Table 91. AB Science SA Company Detail
Table 92. AB Science SA Business Overview
Table 93. AB Science SA Cognitive Impairment Disorders Treatment Product
Table 94. AB Science SA Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 95. AB Science SA Recent Development
Table 96. AbbVie Inc Company Detail
Table 97. AbbVie Inc Business Overview
Table 98. AbbVie Inc Cognitive Impairment Disorders Treatment Product
Table 99. AbbVie Inc Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 100. AbbVie Inc Recent Development
Table 101. CHA Bio & Diostech Co Ltd Company Detail
Table 102. CHA Bio & Diostech Co Ltd Business Overview
Table 103. CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Product
Table 104. CHA Bio & Diostech Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 105. CHA Bio & Diostech Co Ltd Recent Development
Table 106. Echo Pharmaceuticals BV Company Detail
Table 107. Echo Pharmaceuticals BV Business Overview
Table 108. Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Product
Table 109. Echo Pharmaceuticals BV Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 110. Echo Pharmaceuticals BV Recent Development
Table 111. Eisai Co Ltd Company Detail
Table 112. Eisai Co Ltd Business Overview
Table 113. Eisai Co Ltd Cognitive Impairment Disorders Treatment Product
Table 114. Eisai Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 115. Eisai Co Ltd Recent Development
Table 116. GlaxoSmithKline Plc Company Detail
Table 117. GlaxoSmithKline Plc Business Overview
Table 118. GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Product
Table 119. GlaxoSmithKline Plc Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 120. GlaxoSmithKline Plc Recent Development
Table 121. Grifols SA Company Detail
Table 122. Grifols SA Business Overview
Table 123. Grifols SA Cognitive Impairment Disorders Treatment Product
Table 124. Grifols SA Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 125. Grifols SA Recent Development
Table 126. Immungenetics AG Company Detail
Table 127. Immungenetics AG Business Overview
Table 128. Immungenetics AG Cognitive Impairment Disorders Treatment Product
Table 129. Immungenetics AG Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 130. Immungenetics AG Recent Development
Table 131. Otsuka Holdings Co Ltd Company Detail
Table 132. Otsuka Holdings Co Ltd Business Overview
Table 133. Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Product
Table 134. Otsuka Holdings Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 135. Otsuka Holdings Co Ltd Recent Development
Table 136. Merck & Co Inc Company Detail
Table 137. Merck & Co Inc Business Overview
Table 138. Merck & Co Inc Cognitive Impairment Disorders Treatment Product
Table 139. Merck & Co Inc Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 140. Merck & Co Inc Recent Development
Table 141. Kyowa Hakko Kirin Co Ltd Company Detail
Table 142. Kyowa Hakko Kirin Co Ltd Business Overview
Table 143. Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Product
Table 144. Kyowa Hakko Kirin Co Ltd Revenue in Cognitive Impairment Disorders Treatment Business (2018-2023) & (US$ Million)
Table 145. Kyowa Hakko Kirin Co Ltd Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cognitive Impairment Disorders Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cognitive Impairment Disorders Treatment Market Share by Type: 2022 VS 2033
Figure 3. Antiepileptic Drugs Cognitive Impairment Disorders Treatment Features
Figure 4. Antipsychotics Drugs Cognitive Impairment Disorders Treatment Features
Figure 5. Global Cognitive Impairment Disorders Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Cognitive Impairment Disorders Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Cognitive Impairment Disorders Treatment Report Years Considered
Figure 12. Global Cognitive Impairment Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cognitive Impairment Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cognitive Impairment Disorders Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Cognitive Impairment Disorders Treatment Market Share by Players in 2022
Figure 16. Global Top Cognitive Impairment Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognitive Impairment Disorders Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cognitive Impairment Disorders Treatment Revenue in 2022
Figure 18. North America Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cognitive Impairment Disorders Treatment Market Share by Country (2018-2033)
Figure 20. United States Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Cognitive Impairment Disorders Treatment Market Share by Country (2018-2033)
Figure 24. Germany Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Cognitive Impairment Disorders Treatment Market Share by Region (2018-2033)
Figure 32. China Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Cognitive Impairment Disorders Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Cognitive Impairment Disorders Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Cognitive Impairment Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Eli Lilly and Company Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 47. AstraZeneca Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 50. Minerva Neurosciences Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 51. Intra-Cellular Therapies Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 52. Avineuro Pharmaceuticals Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 53. SyneuRx Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 54. Lundbeck Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 55. AB Science SA Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 56. AbbVie Inc Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 57. CHA Bio & Diostech Co Ltd Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 58. Echo Pharmaceuticals BV Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 59. Eisai Co Ltd Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 61. Grifols SA Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 62. Immungenetics AG Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 63. Otsuka Holdings Co Ltd Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 64. Merck & Co Inc Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 65. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in Cognitive Impairment Disorders Treatment Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed